Wells Fargo & Company Evotec Se Transaction History

Wells Fargo & Company

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$10.78 - $15.5 $16,169 - $23,250	1,500 Added 37.5%	5,500 $66,000
Q1 2022 May 16, 2022	BUY	$12.93 - $23.46 $38,764 - $70,333	2,998 Added 299.2%	4,000 $61,000
Q4 2021 Feb 14, 2022	BUY	$22.0 - $25.77 $22,044 - $25,821	1,002 New	1,002 $24,000

2.69M

Ticker EVO
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 353,904,992
Market Cap $1.26B
Description
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.